BeOne Medicines AG (ONC) is expected to report earnings on Thursday, November 5, 2026, after the close. Estimated release time 06:03 ET. Consensus EPS estimate is $1.90.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2025-08-06 | FY2025 Q2 | $0.48 | $0.87 | +81.3% | $1.32B |
| 2024-12-31 | FY2024 Q3 | $-0.88 | $-1.43 | -62.5% | $1.13B |
| 2024-09-30 | FY2024 Q2 | $-2.10 | $-1.16 | +44.8% | $1.00B |
| 2024-06-30 | FY2024 Q1 | $-2.92 | $-1.15 | +60.6% | $929.17M |
| 2024-03-31 | FY2023 Q4 | $-3.45 | $-2.47 | +28.4% | $751.65M |
| 2023-12-31 | FY2023 Q3 | $-2.93 | $2.08 | +171.0% | $634.41M |
| 2023-09-30 | FY2023 Q2 | $-2.98 | $2.08 | +169.8% | $781.31M |
| 2023-06-30 | FY2023 Q1 | $-3.66 | $-3.64 | +0.5% | $595.26M |
ONC has beaten consensus EPS in 7 of its last 8 reported quarters.
See ONC on the live calendar →